KAPA

Conviction 57HealthcareScan · Tue, Sep 8, 2026

KAPA$1.80-2.17%

ResistanceSupportVol 14

Vol MA14 378.69K

Jun 9Jun 26Jul 16Aug 3Aug 20Sep 8

Kairos Pharma, LTD.PHARMACEUTICAL PREPARATIONSwww.kairospharma.com ↗

Price1.80

Change-2.17%

Gap-2.17%

Rel volume0.58×

Avg volume357.43K

Avg $ vol155.43K

SMA 200.6473

SMA 500.4618

SMA 2000.5894

Price vs 50+289.75%

Price vs 200+205.41%

MA stackmixed

50/200 cross—

Supertrendup · 1.31

RSI (14)87

MACD hist0.18

MACD crossbull · 4d

Stoch %K / %D93 / 93

ADX (14)46

+DI / −DI73 / 5

RSI divergence—

MACD divergence—

ATR %+8.00%

ADR %8.56%

52w high1.97

52w low0.2320

From 52w high-8.63%

Above 52w low+675.86%

New 52w highNo

SqueezeOff

Bollinger width380.40%

%B0.97

Donchian pos93.49%

Donchian high1.91

Donchian low0.2200

AVWAP (52w high)0.5801

vs AVWAP high+210.28%

AVWAP (52w low)0.4960

vs AVWAP low+262.87%

OBV trendDown

Chaikin MF (20)-0.14

Today vs 20d0.58×

Avg vol (14d)378.69K

Avg vol (20d)357.43K

Avg $ vol (20d)155.43K

Market cap42.66M

RS 3m (vs SPY)+313.76%

RS 6m (vs SPY)+177.56%

RS line new highYes

Trend template5/8

Technical rank98.5

1 week+650.00%

1 month+366.32%

3 months+300.00%

6 months+185.22%

1 year+4.65%

YTD+146.81%

P/E-7.83

P/B10.18

P/S—

P/FCF—

EPS-0.3000

Div yield—

ROE-129.97%

ROA-122.24%

Debt/Eq—

Current11.98

EV/EBITDA—

Gross margin—

Net margin—

Rev growth—

EPS growth-109.26%

Price target—

Target upside—

Analyst rating—

Institutional—

Ent. value40.03M

Revenue—

Net income-1.39M

Gross profit—

Free cash flow—

IndustryPHARMACEUTICAL PREPARATIONS

ExchangeNYSE

Shares out21.41M

Employees1

ListedMon, Sep 16, 2024

Free float13.45M

Float %62.8%

Short interest364.25K

Days to cover0.6d

Short volume36.5%

Squeeze score8 / 100

Next earnings—

EPS forecast—

Last EPS vs est—

Last surprise—

Setup gradeC

Conviction57 / 100

Pattern quality—

Tech rank98.5 / 100

Group rank—

Status laneNo active setup

Setup direction—

Pattern family

Resistance1.13

Support0.2224

Days since event—

Candle confirm—

News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in KAPA

All disclosures →

No recent disclosed trades by Congress in KAPA. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in KAPA

No recent insider (Form 4) filings in KAPA. Insiders must file within two business days of a trade.

SEC filings

EDGAR filings in KAPA · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.